Cargando…

Lysergic Acid Diethylamide and Mescaline in Experimental Psychiatry

Detalles Bibliográficos
Autor principal:	Freedman, Daniel X.
Formato:	Texto
Lenguaje:	English
Publicado:	1957
Materias:	Book Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2603749/

Ejemplares similares

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
por: Ley, Laura, et al.
Publicado: (2023)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects
por: Dolder, Patrick C., et al.
Publicado: (2017)

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide Microdoses in Healthy Participants
por: Holze, Friederike, et al.
Publicado: (2020)

Effect of lysergic acid diethylamide (LSD) on reinforcement learning in humans
por: Kanen, Jonathan W., et al.
Publicado: (2023)

Lysergic Acid Diethylamide, Psilocybin and Dimethyltryptamine in Depression Treatment: A Systematic Review
por: Więckiewicz, Gniewko, et al.
Publicado: (2021)

d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
por: De Gregorio, Danilo, et al.
Publicado: (2016)

The effect of lysergic acid diethylamide (LSD) on whole-brain functional and effective connectivity
por: Bedford, Peter, et al.
Publicado: (2023)

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex
por: Savino, Aurora, et al.
Publicado: (2021)

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers
por: Ramaekers, Johannes G, et al.
Publicado: (2020)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
por: Gasser, Peter, et al.
Publicado: (2014)

Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers
por: Family, Neiloufar, et al.
Publicado: (2019)

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
por: De Gregorio, Danilo, et al.
Publicado: (2021)

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
por: Kopra, Emma I, et al.
Publicado: (2022)

Self-inflicted neck wounds under influence of lysergic acid diethylamide: A case report and literature review
por: Le Daré, Brendan, et al.
Publicado: (2020)

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
por: Kopra, Emma I, et al.
Publicado: (2023)

Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2020)

Optimized Analysis of Ergot Alkaloids in Rye Products by Liquid Chromatography-Fluorescence Detection Applying Lysergic Acid Diethylamide as an Internal Standard
por: Holderied, Iris, et al.
Publicado: (2019)

Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
por: Holze, Friederike, et al.
Publicado: (2022)

Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice
por: Inserra, Antonio, et al.
Publicado: (2021)

Effects of acute lysergic acid diethylamide on intermittent ethanol and sucrose drinking and intracranial self-stimulation in C57BL/6 mice
por: Elsilä, Lauri V, et al.
Publicado: (2022)

Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT(2A) and ampa in the medial prefrontal cortex (MPFC)
por: Markopoulos, A., et al.
Publicado: (2021)

Systems-level analysis of local field potentials reveals differential effects of lysergic acid diethylamide and ketamine on neuronal activity and functional connectivity
por: Nasretdinov, Azat, et al.
Publicado: (2023)

Acute Lysergic Acid Diethylamide Does Not Influence Reward-Driven Decision Making of C57BL/6 Mice in the Iowa Gambling Task
por: Elsilä, Lauri V., et al.
Publicado: (2020)

Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics
por: Tsochatzis, Emmanouil, et al.
Publicado: (2020)

Cytotoxic, genotoxic, and oxidative stress-related effects of lysergic acid diethylamide (LSD) and phencyclidine (PCP) in the human neuroblastoma SH-SY5Y cell line
por: Jurič, Andreja, et al.
Publicado: (2021)

Validation of a New Sensitive Method for the Detection and Quantification of R and S-Epimers of Ergot Alkaloids in Canadian Spring Wheat Utilizing Deuterated Lysergic Acid Diethylamide as an Internal Standard
por: Cherewyk, Jensen, et al.
Publicado: (2021)

Valyl: Valerianic Acid Diethylamid
Publicado: (1902)

Methods of Lysergic Acid Synthesis—The Key Ergot Alkaloid
por: Jastrzębski, Michał K., et al.
Publicado: (2022)

PM361. The hallucinogen D-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT(1A), D(2) and TAAR(1) receptors
por: Gregorio, Danilo De, et al.
Publicado: (2016)

Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs
por: Tirri, Micaela, et al.
Publicado: (2022)

Reconstituting the complete biosynthesis of D-lysergic acid in yeast
por: Wong, Garrett, et al.
Publicado: (2022)

Rhodococcus erythropolis MTHt3 biotransforms ergopeptines to lysergic acid
por: Thamhesl, Michaela, et al.
Publicado: (2015)

Contribution of a novel gene to lysergic acid amide synthesis in Metarhizium brunneum
por: Britton, Kelcie N., et al.
Publicado: (2022)

Construction of an efficient Claviceps paspali cell factory for lysergic acid production
por: Hu, Mingzhe, et al.
Publicado: (2023)

Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines
por: Kolaczynska, Karolina E., et al.
Publicado: (2022)

Inquiries in Psychiatry the State of Psychiatry
por: Freeman, Hugh
Publicado: (1967)

PSYCHIATRY
Publicado: (1984)

PSYCHIATRY
Publicado: (1964)

PSYCHIATRY
Publicado: (1980)

Psychiatry
Publicado: (1948)

Cannot write session to /tmp/vufind_sessions/sess_omsqhc312rvsclmre1subvj5ks